肌少症对心力衰竭患者预后影响的系统评价

doi:10.3761/j.issn.1672-9234.2022.11.017

摘要/Abstract

摘要：

目的系统评价肌少症对心力衰竭患者预后的影响。方法计算机检索PubMed、Web of Science、Embase、The Cochrane Library、CBM、CINAHL、CNKI、万方和维普数据库，并使用“滚雪球”法检索肌少症对心力衰竭患者预后相关的队列研究，检索时限从建库至2022年6月。由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后，采用RevMan 5.4软件进行Meta分析。结果本研究最终纳入8篇队列研究，包括2 261例患者。Meta分析结果显示，与非肌少症相比，有肌少症的心力衰竭患者全因死亡风险更高[HR=1.32，95%CI（1.18，1.47），P<0.001]，且肌少症也会增加心力衰竭患者心源性不良事件发生的风险[HR=1.01，95%CI（1.01，1.02），P<0.001]。亚组分析结果显示，肌少症对急性失代偿性心力衰竭患者的全因死亡没有影响[HR=1.26，95%CI（1.00，1.59），P=0.05]，但会增加慢性心力衰竭患者全因死亡的风险[HR=1.61，95%CI（1.09，2.36），P=0.02]。结论本研究结果显示肌少症对心力衰竭患者的预后具有预测价值，但受纳入研究数量的限制，结论尚待更多高质量研究验证。

关键词: 心力衰竭, 肌减少症, 预后, Meta分析

Abstract:

Objective To assess the effects of sarcopenia on the prognosis of patients with heart failure（HF）. Methods A comprehensive search was conducted in PubMed，Web of Science，Embase，The Cochrane Library，CBM，CINAHL，CNKI，Wanfang and VIP databases from their inception to June 2022. Cohort studies related to sarcopenia and HF prognosis were collected by “snowball” method. Two reviewers independently screened articles，extracted data，and evaluated risk of bias of the included studies. Meta-analysis was then performed using RevMan 5.4 software. Results Finally 8 cohort studies involving 2 261 patients were included. The meta-analysis showed that HF patients with sarcopenia had a higher risk of all-cause death than those without sarcopenia[HR=1.32， 95%CI（1.18， 1.47），P<0.001]，and sarcopenia also increases the risk of cardiogenic adverse events in HF patients[HR=1.01， 95%CI（1.01， 1.02），P<0.001]. Subgroup analysis showed that sarcopenia had no effect on all-cause death in patients with ADHF[HR=1.26， 95%CI（1.00， 1.59），P=0.05]，but increased the risk of all-cause death in patients with CHF [HR=1.61，95%CI（1.09， 2.36），P=0.02]. Conclusion The results of this study indicate that sarcopenia has predictive value for the prognosis of HF patients. Due to limited quantity and quality of included studies，more high quality studies are needed to verify above conclusions.

Key words: Heart Failure, Sarcopenia, Prognosis, Meta-analysis

李雯艳,袁蓉敬,路娜,苏庆玲,刘瑾,王叶同,王艳红. 肌少症对心力衰竭患者预后影响的系统评价[J]. 中华护理教育, 2022, 19(11): 1046-1051.

LI Wenyan,YUAN Rongjing,LU Na,SU Qingling,LIU Jin,WANG Yetong,WANG Yanhong. The effects of sarcopenia on the prognosis of patients with heart failure：a systematic review[J]. Chinese Journal of Nursing Education, 2022, 19(11): 1046-1051.

图/表 4

参考文献 27

[1]	Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing, 2010, 39(4):412-423. doi: 10.1093/ageing/afq034 pmid: 20392703
[2]	Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia:revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(4):601. doi: 10.1093/ageing/afz046 pmid: 31081853
[3]	周学锋, 刘洪波, 罗永全, 等. 肌少症对老年慢性心力衰竭患者远期预后的影响[J]. 中国心血管杂志, 2017, 22(5):347-351.
	Zhou XF, Liu HB, Luo YQ, et al. Influence of sarcopenia on long-term prognosis in elderly patients with chronic heart failure[J]. Chin J Cardiovasc Med, 2017, 22(5):347-351.
[4]	Fülster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure:results from the studies investigating co-morbidities aggravating heart failure(SICA-HF)[J]. Eur Heart J, 2012, 34(7):512-519. doi: 10.1093/eurheartj/ehs381
[5]	Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia[J]. Geriatr Gerontol Int, 2014, 14(Suppl 1):46-51. doi: 10.1111/ggi.12210
[6]	Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys[J]. Osteoporos Int, 2017, 28(1):189-199. doi: 10.1007/s00198-016-3823-0 pmid: 27885410
[7]	詹莹莹, 陈锐, 刘琳妍, 等. 肌少症与慢性心力衰竭的相关研究进展[J]. 实用老年医学, 2021, 35(7):758-761.
	Zhan YY, Chen R, Liu LY, et al. Research progress on the relationship between sarcopenia and chronic heart failure[J]. Pract Geriatr, 2021, 35(7):758-761.
[8]	von Haehling S, Garfias Macedo T, Valentova M, et al. Muscle wasting as an independent predictor of survival in patients with chronic heart failure[J]. J Cachexia Sarcopenia Muscle, 2020, 11(5):1242-1249. doi: 10.1002/jcsm.12603
[9]	Eschalier R, Massoullié G, Boirie Y, et al. Sarcopenia in patients after an episode of acute decompensated heart failure:an underdiagnosed problem with serious impact[J]. Clin Nutr, 2021, 40(6):4490-4499. doi: 10.1016/j.clnu.2020.12.033 pmid: 33483182
[10]	曾宪涛, 刘慧, 陈曦, 等. Meta分析系列之四:观察性研究的质量评价工具[J]. 中国循证心血管医学杂志, 2012, 4(4):297-299.
	Zeng XT, Liu H, Chen X, et al. Meta-analysis series IV:quality evaluation tools for observational research[J]. Chin J Evid Based Cardiovasc Med, 2012, 4(4):297-299.
[11]	Konishi M, Kagiyama N, Kamiya K, et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction[J]. Eur J Prev Cardiol, 2021, 28(9):1022-1029. doi: 10.1093/eurjpc/zwaa117 pmid: 33624112
[12]	Lopez PD, Nepal P, Akinlonu A, et al. Low skeletal muscle mass independently predicts mortality in patients with chronic heart failure after an acute hospitalization[J]. Cardiology, 2019, 142(1):28-36. doi: 10.1159/000496460 pmid: 30893691
[13]	Matsumura K, Teranaka W, Matsumoto H, et al. Loss of ske-letal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction[J]. ESC Heart Fail, 2020, 7(6):4100-4107.
[14]	Onoue Y, Izumiya Y, Hanatani S, et al. A simple sarcopenia screening test predicts future adverse events in patients with heart failure[J]. Int J Cardiol, 2016, 215:301-306. doi: 10.1016/j.ijcard.2016.04.128 pmid: 27128551
[15]	呼改凤, 田建华, 杨劲, 等. 骨骼肌减少症对70岁及以上慢性心力衰竭患者远期预后的影响[J]. 中华内科杂志, 2018, 57(3):212-215. doi: 10.3760/cma.j.issn.0578-1426.2018.03.012 pmid: 29518867
	Hu GF, Tian JH, Yang J, et al. Sarcopenia and long-term prognosis of patients with chronic heart failure in patients aged 70 years and over[J]. Chin J Intern Med, 2018, 57(3):212-215. doi: 10.3760/cma.j.issn.0578-1426.2018.03.012 pmid: 29518867
[16]	胡正光, 赵雯娟, 曹晓霞, 等. 肌少症对老年射血分数保留心力衰竭患者中期预后影响的研究[J]. 中国心血管杂志, 2020, 25(6):547-550.
	Hu ZG, Zhao WJ, Cao XX, et al. Influence of sarcopenia on mid-term prognosis of elderly patients with heart failure with preserved ejection fraction[J]. Chin J Cardiovasc Med, 2020, 25(6):547-550.
[17]	Chung CJ, Wu C, Jones M, et al. Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement[J]. J Card Fail, 2014, 20(5):310-315. doi: 10.1016/j.cardfail.2014.02.008 pmid: 24569037
[18]	Heitmann BL, Frederiksen P. Thigh circumference and risk of heart disease and premature death:prospective cohort study[J]. BMJ, 2009, 339:b3292. doi: 10.1136/bmj.b3292
[19]	田朝伟, 陈晓辉. 急性心力衰竭的诊治进展:2016ESC急慢性心力衰竭诊断和治疗指南[J]. 中华急诊医学杂志, 2016(7):854-857.
	Tian CW, Chen XH. Advances in diagnosis and treatment of acute heart failure:2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Chin J Emerg Med, 2016(7):854-857.
[20]	Oshima Y, Ouchi N, Sato K, et al. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart[J]. Circulation, 2008, 117(24):3099-3108. doi: 10.1161/CIRCULATIONAHA.108.767673 pmid: 18519848
[21]	尹巧香, 张伟, 张蓝宁, 等. 老年营养风险评估预测急性失代偿性心力衰竭患者全因死亡[J]. 中国临床保健杂志, 2021, 24(2):243-247.
[22]	李小宇, 杨淑芳, 秦俭, 等. 老年急性心力衰竭住院患者近期预后的影响因素分析[J]. 中华老年多器官疾病杂志, 2013, 12(12):908-911.
	Li XY, Yang SF, Qin J, et al. Impact factors on short-term prognosis in senile inpatients with acute heart failure[J]. Chin J Mult Organ Dis Elder, 2013, 12(12):908-911.
[23]	安素, 蒋芸璐, 王华英, 等. 老年慢性心力衰竭病人血清suPAR、MSTN水平与心功能和预后的关系[J]. 实用老年医学, 2022, 36(1):65-68,72.
	An S, Jiang YL, Wang HY, et al. Serum levels of su PAR and MSTN in elderly patients with chronic heart failure and their relationship with cardiac function and prognosis[J]. Pract Geriatr, 2022, 36(1):65-68,72.
[24]	Narumi T, Watanabe T, Kadowaki S, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure[J]. Eur J Intern Med, 2015, 26(2):118-122. doi: 10.1016/j.ejim.2015.01.008 pmid: 25657117
[25]	Campos AM, Moura FA, Santos SN, et al. Sarcopenia,but not excess weight or increased caloric intake,is associated with coronary subclinical atherosclerosis in the very elderly[J]. Athe-rosclerosis, 2017, 258:138-144.
[26]	dos Santos MR, Saitoh M, Ebner N, et al. Sarcopenia and endothelial function in patients with chronic heart failure:results from the studies investigating comorbidities aggravating heart failure(SICA-HF)[J]. J Am Med Dir Assoc, 2017, 18(3):240-245. doi: 10.1016/j.jamda.2016.09.006
[27]	Jankowska EA, Biel B, Majda J, et al. Anabolic deficiency in men with chronic heart failure:prevalence and detrimental impact on survival[J]. Circulation, 2006, 114(17):1829-1837. pmid: 17030678